Comparison between D.K.Enterprises Global IPO and Nidan Laboratories IPO.
D.K.Enterprises Global IPO is a SME Fixed Price IPO proposed to list at NSE SME while Nidan Laboratories IPO is a SME Fixed Price proposed to list at NSE SME.
| D.K.Enterprises Global IPO | Nidan Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Broking Ltd. | First Overseas Capital Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | NNM Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of D.K.Enterprises Global IPO is up to ₹7.58 Cr whereas the issue size of the Nidan Laboratories IPO is up to ₹47.50 Cr. The final issue price of D.K.Enterprises Global IPO is ₹40.00 per share and of Nidan Laboratories IPO is ₹125.00 per share.
| D.K.Enterprises Global IPO | Nidan Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹40.00 per share | ₹125.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 1000 shares |
| Fresh Issue Size | 18,96,000 shares | 38,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹7.58 Cr | up to ₹47.50 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 18,96,000 shares | 38,00,000 shares |
| Issue Size Total (Amount) | up to ₹7.58 Cr | up to ₹47.50 Cr |
D.K.Enterprises Global IPO opens on Oct 07, 2021, while Nidan Laboratories IPO opens on Oct 28, 2021. The closing date of D.K.Enterprises Global IPO and Nidan Laboratories IPO is Oct 12, 2021, and Nov 02, 2021, respectively.
| D.K.Enterprises Global IPO | Nidan Laboratories IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Oct 07, 2021 | Oct 28, 2021 |
| Issue Close | Oct 12, 2021 | Nov 02, 2021 |
| Basis Of Allotment (Tentative) | Oct 18, 2021 | Nov 09, 2021 |
| Initiation of Refunds (Tentative) | Oct 20, 2021 | Nov 10, 2021 |
| Credit of Share (Tentative) | Oct 20, 2021 | Nov 11, 2021 |
| Listing date (Tentative) | Oct 22, 2021 | Nov 12, 2021 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
D.K.Enterprises Global IPO P/E ratio is , as compared to Nidan Laboratories IPO P/E ratio of .
| D.K.Enterprises Global IPO | Nidan Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.88 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.30 | 71.22 | ||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||
In the D.K.Enterprises Global IPO Retail Individual Investors (RII) are offered 9,48,000 shares while in Nidan Laboratories IPO retail investors are offered 9,48,000 shares. Qualified Institutional Buyers (QIB) are offered in D.K.Enterprises Global IPO and in Nidan Laboratories IPO.
| D.K.Enterprises Global IPO | Nidan Laboratories IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,02,000 shares | 2,00,000 shares |
| QIB | ||
| NII | 9,48,000 shares | 19,00,000 shares |
| RII | 9,48,000 shares | 19,00,000 shares |
| Employee | ||
| Others | ||
| Total | 18,96,000 shares | 38,00,000 shares |
D.K.Enterprises Global IPO subscribed 12.50x in total, whereas Nidan Laboratories IPO subscribed 1.80x.
| D.K.Enterprises Global IPO | Nidan Laboratories IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 7.43x | 0.15x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 17.58x | 3.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 12.50x | 1.80x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
